u/CamelEcstatic9503

I have an opportunity to participate in the phase 3 trial of this drug at Duke Medical Center . However, it appears that it did not mean its primary endpoint in phase 2. If you read the abstract, it says there was no statistical benefit. Was anyone in that trial? The way my doctor explained it the extended use of the drug showed promise after the trial was over. Trying to decide if it’s worth the effort to drive to Duke once a month for two years. Ironically, if I didn’t do the trial and the drug turned out to work, I would never be able to afford it lol. anyone have any firsthand information on the phase 2 trial?